Interferon treatment for chronic hepatitis C: a family impact study.
Hepatitis C virus is estimated to affect 170 million people worldwide. Infection can lead to cirrhosis, liver failure, or liver cancer. Hepatitis C is unique among chronic illnesses, in that potentially curative treatment is available. Therapy is of prolonged duration and associated with multiple physiological and psychological side effects. These side effects have the potential to impact not only the individual receiving therapy but also their family and the day-to-day functioning of the family unit.This paper describes data and findings obtained from a family impact study instigated to explore the repercussions of interferon treatment for chronic hepatitis C on family life, from both the perspectives of individuals who had received treatment and their family members. An exploratory study was conducted using semi-structured focus groups.Findings reveal the treatment impacted on physical, emotional, relational, and financial domains. The major themes identified were resilience, loss, hardship, anger and irritability, and secrecy. The side-effect profile of therapy exerted significant and previously unforeseen impacts on family relationships, both negatively and positively. Treatment receivers tended to view their experiences as having more adverse impact, while family members, although affected, demonstrated considerable resilience and coping.
Blacklaws
Helen
H
Teaching and Research Unit, Northern Sydney Central Coast Area Health Service, Gosford, New South Wales 2250, Australia. hblacklaws@nsccahs.health.nsw.gov.au
Veysey
Heather
H
Skinner
Virginia
V
Reid
Rachel Sheather
RS
Hawken
Glenn
G
Veysey
Martin
M
D000223:Adaptation, Psychological; D000786:Anger; D000998:Antiviral Agents / Q000008:administration & dosage*; D003219:Confidentiality; D005190:Family / Q000523:psychology; D005195:Family Relations; D017144:Focus Groups; D006306:Health Surveys; D016174:Hepacivirus / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000451:nursing*; D006801:Humans; D007372:Interferons / Q000008:administration & dosage*; D011788:Quality of Life / Q000523:psychology; D055500:Resilience, Psychological; D011795:Surveys and Questionnaires
D000998:Antiviral Agents; D007372:Interferons